IP

Institut Paoli-Calmettes at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Institut Paoli-Calmettes takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on Claudin 18.2-targeted therapy in gastric and gastroesophageal junction adenocarcinoma and on PSMA-targeted radioligand therapy in prostate cancer. Other sessions cover how electric field therapy combines with other cancer treatments, the primary tumour in metastatic kidney cancer and less frequent immunotherapy dosing.

OrganizationESMO 2026 Attendance
IP
Institut Paoli-Calmettes
Marseille, France
Cancer centre & hospital
Comprehensive cancer centre in Marseille, France, part of the Unicancer network of French cancer centres.
Satellite
Fri Oct 23
18:25–18:35
Unboxing first-line treatment choice
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma
Gastrointestinal cancers
Satellite
Fri Oct 23
18:35–18:45
Selecting your piece: CLDN18.2 targeted therapies
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with The Institute of Cancer Research, Hospital Universitario de Navarra, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Satellite
Fri Oct 23
18:55–19:10
The emerging picture: Precision medicine in clinical decision-making
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Hematology Oncology Practice Hamburg, Hospital Universitario de Navarra, The Institute of Cancer Research
Gastrointestinal cancers
Satellite
Fri Oct 23
19:20–19:40
The complete picture: Enhancing patient care
Astellas - Solving the puzzle: Optimising practice in CLDN18.2+ gastric/GEJ adenocarcinoma · with Hospital Universitario de Navarra, The Institute of Cancer Research, Hematology Oncology Practice Hamburg
Gastrointestinal cancers
Satellite
Sat Oct 24
13:00–14:30
Satellite
Sat Oct 24
13:00–13:05
Welcome, introduction, and objectives for the session
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Satellite
Sat Oct 24
13:05–13:15
PSMA RLT in prostate cancer: What the guidelines say in 2026
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Satellite
Sat Oct 24
14:17–14:27
Future landscape in Prostate Cance
Novartis - PSMA-targeted RLT in Prostate Cancer: Present and future
Genitourinary cancers
Talk
Sun Oct 25
13:00–13:18
Mechanisms of action and synergies of electric fields with other anticancer modalities
ESMO Colloquium supported by Novocure GmbH - Electric field therapy devices for the treatment of cancer: Expanding treatment paradigms in solid tumour oncology
Talk
Mon Oct 26
10:40–11:00
What to do with the primary in extreme responders
Response-based adaptive strategies in primary metastatic kidney cancer
Genitourinary cancers
Abstract
Mon Oct 26
16:54–17:06

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Institut Paoli-Calmettes

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction